|
FARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.38444811170757E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.76979550406509E-11 |
| Normal-vs-Stage2 |
1.993180E-04 |
| Normal-vs-Stage3 |
8.62939999457524E-08 |
| Normal-vs-Stage4 |
2.00860439392159E-11 |
| Stage1-vs-Stage2 |
7.801000E-01 |
| Stage1-vs-Stage3 |
9.612200E-02 |
| Stage1-vs-Stage4 |
3.158200E-02 |
| Stage2-vs-Stage3 |
3.024000E-01 |
| Stage2-vs-Stage4 |
5.484100E-02 |
| Stage3-vs-Stage4 |
2.794000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.08144612656724E-12 |
| Normal-vs-AfricanAmerican |
5.38290523266483E-11 |
| Normal-vs-Asian |
8.358200E-02 |
| Caucasian-vs-AfricanAmerican |
7.363400E-01 |
| Caucasian-vs-Asian |
4.724600E-01 |
| AfricanAmerican-vs-Asian |
6.697000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31672450720544E-13 |
| Normal-vs-Female |
4.15250001051248E-09 |
| Male-vs-Female |
6.440200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.80600045608071E-11 |
| Normal-vs-Extreme_Weight |
3.17623705115011E-12 |
| Normal-vs-Obese |
8.1494000436777E-09 |
| Normal-vs-Extreme_Obese |
7.693900E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.253400E-01 |
| Normal_Weight-vs-Obese |
1.236820E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.661000E-01 |
| Extreme_Weight-vs-Obese |
3.021800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.105400E-01 |
| Obese-vs-Extreme_Obese |
8.689600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.201300E-03 |
| Normal-vs-Age(41-60Yrs) |
9.88310544514093E-11 |
| Normal-vs-Age(61-80Yrs) |
2.00583993859027E-12 |
| Normal-vs-Age(81-100Yrs) |
1.975360E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.216200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.057400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.497800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.880800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.085200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.158000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.35529970263826E-10 |
| Normal-VS-Type2 PRCC |
5.31250043955822E-10 |
| Normal-VS-KIRP CIMP |
1.64046554118613E-12 |
| Normal-VS-Unclassified PRCC |
6.89429999756186E-08 |
| Type1 PRCC-VS-Type2 PRCC |
7.248500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.02410000005315E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.129550E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.56339999999711E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.931200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.560100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08390000308489E-08 |
| Normal-vs-N1 |
8.60939997071597E-09 |
| Normal-vs-N2 |
2.08749999508484E-08 |
| N0-vs-N1 |
2.315200E-01 |
| N0-vs-N2 |
2.280000E-01 |
| N1-vs-N2 |
4.076600E-01 |
|
|
